KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Halozyme Therapeutics (HALO) Interest Coverage Ratio: 2013-2025

Historic Interest Coverage Ratio for Halozyme Therapeutics (HALO) over the last 13 years, with Sep 2025 value amounting to 50.73.

  • Halozyme Therapeutics' Interest Coverage Ratio rose 40.62% to 50.73 in Q3 2025 from the same period last year, while for Sep 2025 it was 41.53, marking a year-over-year increase of 63.47%. This contributed to the annual value of 30.48 for FY2024, which is 69.39% up from last year.
  • Latest data reveals that Halozyme Therapeutics reported Interest Coverage Ratio of 50.73 as of Q3 2025, which was up 10.10% from 46.07 recorded in Q2 2025.
  • In the past 5 years, Halozyme Therapeutics' Interest Coverage Ratio ranged from a high of 53.11 in Q2 2021 and a low of 10.97 during Q2 2022.
  • Moreover, its 3-year median value for Interest Coverage Ratio was 25.91 (2024), whereas its average is 29.25.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first surged by 4,384.26% in 2021, then slumped by 79.34% in 2022.
  • Over the past 5 years, Halozyme Therapeutics' Interest Coverage Ratio (Quarterly) stood at 27.51 in 2021, then tumbled by 40.74% to 16.30 in 2022, then rose by 18.72% to 19.36 in 2023, then soared by 99.72% to 38.66 in 2024, then surged by 40.62% to 50.73 in 2025.
  • Its last three reported values are 50.73 in Q3 2025, 46.07 for Q2 2025, and 31.28 during Q1 2025.